These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21553090)

  • 1. Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with ¹⁸F-dopa brain PET in normal controls and patients with Parkinson's disease.
    Oehme L; Perick M; Beuthien-Baumann B; Wolz M; Storch A; Löhle M; Herting B; Langner J; van den Hoff J; Reichmann H; Kotzerke J
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1550-9. PubMed ID: 21553090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
    Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders.
    Jaimini A; Tripathi M; D'Souza MM; Panwar P; Sharma R; Mehta S; Pandey S; Saw S; Singh D; Solanki Y; Mishra AK; Mondal A
    Nucl Med Commun; 2013 May; 34(5):426-31. PubMed ID: 23458855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson's disease patients.
    Chang IC; Lue KH; Hsieh HJ; Liu SH; Kao CH
    Ann Nucl Med; 2011 Dec; 25(10):796-803. PubMed ID: 21887536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
    Eshuis SA; Jager PL; Maguire RP; Jonkman S; Dierckx RA; Leenders KL
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):454-62. PubMed ID: 19037637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of exposure to pesticides in the etiology of Parkinson's disease: a
    Djaldetti R; Steinmetz A; Rigbi A; Scherfler C; Poewe W; Roditi Y; Greenbaum L; Lorberboym M
    J Neural Transm (Vienna); 2019 Feb; 126(2):159-166. PubMed ID: 30426251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
    Jokinen P; Helenius H; Rauhala E; Brück A; Eskola O; Rinne JO
    J Nucl Med; 2009 Jun; 50(6):893-9. PubMed ID: 19443601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications.
    Löhle M; Mende J; Wolz M; Beuthien-Baumann B; Oehme L; van den Hoff J; Kotzerke J; Reichmann H; Storch A
    Neurology; 2016 Jan; 86(3):231-40. PubMed ID: 26718573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
    Suzuki M; Ito H; Kodaka F; Takano H; Kimura Y; Fujiwara H; Sasaki T; Takahata K; Nogami T; Nagashima T; Nengaki N; Kawamura K; Zhang MR; Varrone A; Halldin C; Okubo Y; Suhara T
    Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior cingulate dopamine turnover and behavior change in Parkinson's disease.
    Gallagher CL; Bell B; Palotti M; Oh J; Christian BT; Okonkwo O; Sojkova J; Buyan-Dent L; Nickles RJ; Harding SJ; Stone CK; Johnson SC; Holden JE
    Brain Imaging Behav; 2015 Dec; 9(4):821-7. PubMed ID: 25511521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease.
    Eshuis SA; Maguire RP; Leenders KL; Jonkman S; Jager PL
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):200-9. PubMed ID: 16228235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
    Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK
    J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putaminal Dopamine Turnover in de novo Parkinson's Disease Predicts Later Neuropsychiatric Fluctuations but Not Other Major Health Outcomes.
    Löhle M; Hermann W; Hausbrand D; Wolz M; Mende J; Beuthien-Baumann B; Oehme L; van den Hoff J; Kotzerke J; Reichmann H; Hermann A; Storch A
    J Parkinsons Dis; 2019; 9(4):693-704. PubMed ID: 31381528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
    Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
    Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.
    Rakshi JS; Uema T; Ito K; Bailey DL; Morrish PK; Ashburner J; Dagher A; Jenkins IH; Friston KJ; Brooks DJ
    Brain; 1999 Sep; 122 ( Pt 9)():1637-50. PubMed ID: 10468504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease.
    Ceravolo R; Piccini P; Bailey DL; Jorga KM; Bryson H; Brooks DJ
    Synapse; 2002 Mar; 43(3):201-7. PubMed ID: 11793426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple algorithm for subregional striatal uptake analysis with partial volume correction in dopaminergic PET imaging.
    Lue KH; Lin HH; Kao CH; Hsieh HJ; Liu SH; Chuang KS
    Ann Nucl Med; 2014 Jan; 28(1):33-41. PubMed ID: 24135967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.
    Dhawan V; Ma Y; Pillai V; Spetsieris P; Chaly T; Belakhlef A; Margouleff C; Eidelberg D
    J Nucl Med; 2002 Oct; 43(10):1324-30. PubMed ID: 12368370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.